# Fibrin Sealant for the Sealing of Dura Sutures

> **NCT00681824** · PHASE2 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 95 (actual)

## Conditions studied

- Pathological Processes in the Posterior Fossa
- Dura Defects

## Interventions

- **BIOLOGICAL:** Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/mL thrombin and synthetic aprotinin (FS VH S/D 500 s-apr)
- **PROCEDURE:** Standard of care

## Key facts

- **NCT ID:** NCT00681824
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2013-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00681824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00681824, "Fibrin Sealant for the Sealing of Dura Sutures". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00681824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*